Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis
Clinical trial NCT00692172 · COMPLETED
Trial details
- NCT number
- NCT00692172
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Primary completion
- 2004-11-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.